Effectiveness of clindamycin and rifampicin combination-therapy in hidradenitis suppurativa: a six-months prospective study.

Effectiveness of clindamycin and rifampicin combination-therapy in hidradenitis suppurativa: a six-months prospective study. Br J Dermatol. 2020 Sep 30;: Authors: Yao Y, Jørgensen AR, Ring HC, Thomsen SF Abstract treatment of Hidradenitis Suppurativa (HS) with systemic antibiotics are first line therapy according to European S1 guidelines [1]. Yet, despite being the most investigated antibiotic regimen in HS, the evidence-based literature on clindamycin and rifampicin in HS is limited and primarily based on retrospective studies [2-5]. Additionally, despite the lack of evidence on the long-term risks, the suggested treatment duration is 10 weeks due to the risk of side effects and concerns regarding antibiotic resistance [6]. PMID: 33000461 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33000461?dopt=Abstract

Source: The British Journal of Dermatology - September 29, 2020 Category: Dermatology Authors: Yao Y, Jørgensen AR, Ring HC, Thomsen SF Tags: Br J Dermatol Source Type: research